Fundraising Fox
Imu Biosciences
London, GB · Founded 2019 · 79 employees on LinkedIn · 7 known investors
Find your way into Imu Biosciences
Sign up to see every warm intro you have to Imu Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Imu Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
IMU Biosciences builds an immune-system analysis platform that measures over 100 million datapoints from a single blood sample across large patient populations, an approach it calls HD Immunology. The company applies this high-resolution immune profiling to uncover immune mechanisms and support precision diagnosis, monitoring, and treatment of disease.
Founders & leadership
Imu Biosciences was founded in 2019 by Thomas Hayday PhD, Adam Laing PhD, Mario Cantero MBA, and Adam Laing.
Investors · 7
How we know: the VCSheet dataset · Not right? Tell us
.jpeg){kind=logo}
How we know: IQ Capital's portfolio page · bioindustry.org · Not right? Tell us
How we know: LifeX Ventures's portfolio page · Not right? Tell us
How we know: Molten Ventures's portfolio page · a partner's Signal profile · bioindustry.org · the VCSheet dataset · Not right? Tell us
Also in the syndicate · 2
Funding
SEC filings, press & company announcements$53M disclosed across 1 round · 2026
- $53MSeries AJun 2026 · 9 sources
IQ Capital (lead), Molten Ventures (lead), Meltwind, The British Business Bank
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Imu Biosciences do?
- IMU Biosciences builds an immune-system analysis platform that measures over 100 million datapoints from a single blood sample across large patient populations, an approach it calls HD Immunology. The company applies this high-resolution immune profiling to uncover immune mechanisms and support precision diagnosis, monitoring, and treatment of disease.
- Who founded Imu Biosciences?
- Imu Biosciences was founded by Thomas Hayday PhD, Adam Laing PhD, Mario Cantero MBA, Adam Laing in 2019.
- Who are Imu Biosciences's investors?
- Imu Biosciences's investors include Expa, IQ Capital, Kfund, LifeX Ventures, Molten Ventures.
- How much funding has Imu Biosciences raised?
- Imu Biosciences has disclosed $53M raised across 1 round.
- Where is Imu Biosciences headquartered?
- Imu Biosciences is headquartered in London, GB.